Loading…
Monday, June 25 • 11:00am - 12:15pm
#109: The Who, What, How, When, and Why of Using Mobile Technology in Clinical Trials

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-522-L04-P; CME 1.25; IACET 1.25; RN 1.25

Panelists will discuss how they have implemented recommendations from CTTI’s Mobile Clinical Trials projects to advance the use of mobile technology in clinical trials, as well as how others can adopt these strategies.

Learning Objectives

Describe recommendations for successfully incorporating mobile technology in regulatory submission trials; Identify approaches for developing novel endpoints, overcoming legal and regulatory barriers, and incorporating mobile devices in clinical trials while accounting for site and patient perspectives; Discuss opportunities to implement recommendations in attendee organizations.

Chair

Robert A. DiCicco, PharmD

Speaker

Panelist
Cynthia Geoghegan

Panelist
Philip Coran

Panelist
Jan Hewett, BSN, JD


Speakers
avatar for Philip Coran

Philip Coran

Principal, Global Compliance and Strategy, Medidata Solutions
Phil Coran is a Principal of Global Compliance & Strategy at Medidata. Prior to joining Medidata, Phil was at Pfizer for 12 years in the Medical Quality Assurance and Internal Audit groups. From 1999-2001, Phil was an IT Risk Consultant at Deloitte & Touche & Arthur Andersen accounting... Read More →
avatar for Robert DiCicco

Robert DiCicco

Executive Consultant, TransCelerate Biopharma Inc.
Rob DiCicco is an executive consultant for TransCelerate. He is the Executive Sponsor for the Common Protocol Template Project and was one of the Team Leads on CTTI’s Mobile Clinical Trials Novel Endpoints Project. He has over 25 years of experience in clinical development. His... Read More →
avatar for Cynthia Geoghegan

Cynthia Geoghegan

Patient Representative, Patients and Partners LLC
A patient advocate and cancer survivor with decades of health policy, communications and non-profit leadership experience, Cindy Geoghegan founded Patient & Partners to ensure that the patient perspective is represented throughout industry, academic, government and non-profit efforts... Read More →
avatar for Jan Hewett

Jan Hewett

Regulatory Counsel for Policy, OSI, CDER, FDA
Jan Hewett is currently Regulatory Counsel (Policy) at the FDA (CDER – Office of Scientific Investigations). Before joining OSI, Jan served in various HRPP & IRB Director, Snr. Grants & Contracts and Clinical Research Nurse Coordinator roles. She has also served as a member of the... Read More →

Monday June 25, 2018 11:00am - 12:15pm
Room 258C Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  02: ClinTrials -ClinOps, Forum